Mesa Laboratories, Inc. MLAB · SEC Filings

717

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and...

Price127.82

Market Cap715.26 M

Float4.95 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 10, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jun 2, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Feb 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWMesa Labs Announces Second Quarter Fiscal Year 2027 Results, Savings Plan, Share Repurchase Program, and First Full-Year Guidance

Nov 9, 2026

8-K

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by $9.3 Million

Oct 13, 2026

8-K

Mesa Laboratories, Inc. Reports Voting Results from 2026 Annual Meeting of Shareholders

Sep 8, 2026

8-K

Mesa Laboratories Announces First Quarter Fiscal 2027 Financial Results

Aug 10, 2026

8-K

Mesa Laboratories, Inc. Amends and Restates Code of Ethics and Business Conduct

Jul 30, 2026

8-K

Mesa Laboratories, Inc. Appoints Lyndsey Crennen as Chief Accounting Officer

Jun 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

ATM | Offering amount: $150,000,000

Apr 5, 2022

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 10, 2020

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 8, 2020

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Aug 8, 2019

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Aug 8, 2019

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Aug 6, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 3, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 30, 2023

S-3ASR

SHELF

Apr 5, 2022

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 30, 2021

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 8, 2019

S-3ASR

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Aug 6, 2019

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 22, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 11, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 19, 2024

PX14A6G

Form PX14A6G - Notice of exempt solicitation submitted by non-management

Jul 28, 2023

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 14, 2023

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Jul 3, 2023

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Apr 2, 2024

CORRESP

Form CORRESP - Correspondence

Mar 25, 2024

LETTER

Form UPLOAD - SEC-generated letter

Mar 20, 2024

CORRESP

Form CORRESP - Correspondence

Mar 15, 2024

LETTER

Form UPLOAD - SEC-generated letter

Mar 6, 2024

SD

Form SD - Specialized disclosure report

May 27, 2022